MedDataX Logo

Design of Optimally-diagnostic Skin Test Solutions for Diagnosis of Sensitisation to a Pollen and Dust Mite Mixture.

NCT ID: NCT00665483

Last Updated: 2013-11-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Study Classification

INTERVENTIONAL

Study Start Date

2007-03-31

Study Completion Date

2010-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Multicenter Skin Prick Test

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type I Allergy

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Skin Prick Test

Group Type EXPERIMENTAL

Skin Prick Test

Intervention Type OTHER

Skin Prick Test

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Skin Prick Test

Skin Prick Test

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* anamnesis referring to suspicion of an IgE-mediated allergy
* positive Skin Prick Test in the medical history to at least one of the investigational allergens with an existing anamnesis

Exclusion Criteria

* serious chronic diseases
* Other perennial allergies
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Allergopharma GmbH & Co. KG

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nicola Wagner, MD

Role: PRINCIPAL_INVESTIGATOR

Klinikum Darmstadt

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Klinikum Darmstadt

Darmstadt, Hesse, Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Related Links

Access external resources that provide additional context or updates about the study.

http://www.allergopharma.de

Leader in specific allergy research and therapy

https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005304-14/DE

Click here for information about this trial in the European Clinical Trials Register

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2006-005304-14

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

AL0205PR

Identifier Type: -

Identifier Source: org_study_id